CA2400240A1 - Multiplex ligatable probe amplification - Google Patents
Multiplex ligatable probe amplification Download PDFInfo
- Publication number
- CA2400240A1 CA2400240A1 CA002400240A CA2400240A CA2400240A1 CA 2400240 A1 CA2400240 A1 CA 2400240A1 CA 002400240 A CA002400240 A CA 002400240A CA 2400240 A CA2400240 A CA 2400240A CA 2400240 A1 CA2400240 A1 CA 2400240A1
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- probe
- probes
- sample
- complementary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Abstract
Described is an improved multiplex ligation-dependent amplification method for detecting the presence and quantification of at least one specific single stranded target nucleic acid sequence in a sample using a plurality of probe sets of at least two probes, each of which includes a target specific region and a non-complementary region comprising a primer binding site. The probes belonging to the same set are ligated together when hybridised to the target nucleic acid sequence and amplified by a suitable primer set. By using a femtomolar amount of the probes a large number of different probe sets can be used to simultaneously detect and quantify a corresponding large number of target sequences with high specificity.
Claims (40)
1. Method for detecting in a sample, comprising a plurality of sample nucleic acids of different sequence, the presence of at least one specific single stranded target nucleic acid sequence comprising a first and a second segment, and optionally a third segment being located between the first and second segments, the segments located essentially adjacent to one another, comprising, in a reaction mixture, the steps of:
- contacting the sample nucleic acids with a plurality of different probe sets, each probe set comprising - a first nucleic acid probe having - a first target specific region complementary to the first segment of said target nucleic acid sequence and - a first non-complementary region, 3'from the first region, being essentially non-complementary to said target nucleic acid sequence, comprising a first tag sequence, - a second nucleic acid probe having - a second target specific region complementary to the second segment of said target nucleic acid sequence and - a second non-complementary region, 5'from the second region, being essentially non-complementary to said target nucleic acid sequence, comprising a second tag sequence, and, optionally, - a third nucleic acid probe having a third target specific region, complementary to the third segment, - incubating the plurality of sample nucleic acids with the probes allowing hybridisation of complementary nucleic acids, - connecting to one another the first, second and optionally the third probes, hybridised to the first, second and, if present, third segment of the same target nucleic acid sequence, respectively, the hybridised probes being located essentially adjacent to one another, forming a connected probe assembly, - amplifying the connected probe assemblies, wherein amplification is initiated by binding of a first nucleic acid primer specific for the first tag sequence followed by elongation thereof, - detecting an amplicon, wherein the amount of at least the first probe of at least one probe set in the mixture is less than 40 femtomoles, and the molar ratio between the first primer and the first probe being at least 200.
- contacting the sample nucleic acids with a plurality of different probe sets, each probe set comprising - a first nucleic acid probe having - a first target specific region complementary to the first segment of said target nucleic acid sequence and - a first non-complementary region, 3'from the first region, being essentially non-complementary to said target nucleic acid sequence, comprising a first tag sequence, - a second nucleic acid probe having - a second target specific region complementary to the second segment of said target nucleic acid sequence and - a second non-complementary region, 5'from the second region, being essentially non-complementary to said target nucleic acid sequence, comprising a second tag sequence, and, optionally, - a third nucleic acid probe having a third target specific region, complementary to the third segment, - incubating the plurality of sample nucleic acids with the probes allowing hybridisation of complementary nucleic acids, - connecting to one another the first, second and optionally the third probes, hybridised to the first, second and, if present, third segment of the same target nucleic acid sequence, respectively, the hybridised probes being located essentially adjacent to one another, forming a connected probe assembly, - amplifying the connected probe assemblies, wherein amplification is initiated by binding of a first nucleic acid primer specific for the first tag sequence followed by elongation thereof, - detecting an amplicon, wherein the amount of at least the first probe of at least one probe set in the mixture is less than 40 femtomoles, and the molar ratio between the first primer and the first probe being at least 200.
2. Method according to claim 1, wherein the amount of at least the first probe of each probe set in the mixture is less than 40 femtomoles, and the molar ratio between the first primer and the first probe being at least 200.
3. Method according to claim 1 or 2, wherein the molar ratio between the first primer and the first probe of at least one probe set, preferably of each probe set, is at least 400, preferably at least 800, most preferably at least 1600.
4. Method according to any of the preceding claims, wherein the molar amount of at least the first probe of at least one probe set, preferably of each probe set is less than 10 femtomoles, preferably 4-5 femtomoles.
5. Method according to any of the preceding claims, wherein the first tag sequences of the first nucleic acid probes of the different probe sets are identical.
6. Method according to any of the preceding claims, wherein the amplification step comprises binding of a second nucleic acid primer, specific to the second tag sequence, to the elongation product of the second primer.
7. Method according to any of the preceding claims, wherein the molar amount of the second probe of at least one probe set, preferably of each probe set, is less than 40 femtomoles, preferably less than 10 femtomoles, most preferably 4-5 femtomoles.
8. Method according to any of the preceding claims, wherein the molar ratio between the second primer and the second probe is at least 200, preferably at least 500, more preferably at least 1000, most preferably at least 2000.
9. Method according to any of the preceding claims, wherein the second tag sequences of the second nucleic acid probes of the different probe sets are identical.
10. Method according to claim 9, wherein the molar ratio between the second primer and the total amount of probes present in the reaction mixture is at least 5, preferably at least 15 and more preferably at least 25.
11. Method according to any of the preceding claims, wherein the reaction mixture comprises at least 10 sets, preferably at least 20, most preferably 30-40 different sets of probes.
12. Method according to any of the preceding claims, wherein at least a portion of the unhybridised probes remain in the reaction mixture during the incubating step, the connecting step and the amplifying step.
13. Method according to any of the preceding claims, wherein all unhybridised probes remain in the reaction mixture during the incubating step, the connecting step and the amplifying step.
14. Method according to any of the preceding claims, wherein the contacting step, the connecting step and the amplification step are carried out in the same reaction vessel, the reaction mixture not being removed from the said vessel during the said steps.
15. Method according to any of the preceding claims, wherein, in a reaction mixture of 3-150 µl, the amount of:
sample nucleic acid is 10 - 1000 ng, the first probe of each probe set is 0,5 - 40 fmol, the second probe of each probe set is 0 - 40 fmol, each first primer is 5 - 20 pmol, each second primer is 0 - 20 pmol.
sample nucleic acid is 10 - 1000 ng, the first probe of each probe set is 0,5 - 40 fmol, the second probe of each probe set is 0 - 40 fmol, each first primer is 5 - 20 pmol, each second primer is 0 - 20 pmol.
16. Method according to any of the preceding claims, wherein the reaction mixture, at least during the connection step, comprises ligation activity, connecting the essentially adjacent probes.
17. Method according to claim 16, wherein the ligation activity is performed with a thermostable nucleic acid ligase, at least 95% of the activity being inactivated within ten minutes above a temperature of approximately 95 °C.
18. Method according to any of the preceding claims, wherein at least one nucleic acid probe comprises enzymatic template directed polymerised nucleic acid.
19. Method according to claim 18, wherein at least one probe is generated by digestion of DNA with a restriction endonuclease.
20. Method according to claim 18 or 19, wherein this restriction endonuclease is capable of cutting at least one strand of the DNA outside the enzyme recognition site sequence on said DNA.
21. Method according to any of the claims 19-20, wherein the DNA used is single stranded DNA made partially double stranded by annealing of one or more oligonucleotides.
22. Method according to any of the preceding claims, wherein at least one probe comprises two separate probe parts being connected together in the step of connecting the essentially adjacent probes.
23. Method according to claim 22, wherein at least one of said probe parts comprises enzymatic template directed polymerised nucleic acid prior to said connecting.
24. Method according to any of the preceding claims, further comprising extending a 3' end of a hybridised probe prior to the connecting step.
25. Method according to any of the preceding claims, further comprising providing said sample with a competitor nucleic acid comprising a nucleic acid sequence capable of competing with at least one probe for hybridisation to a target nucleic acid.
26. Method according to any of the preceding claims, wherein said sample is further provided with a known amount a target sequence for one or more probe pairs, prior to the connection step.
27. Method according to any of the preceding claims, wherein said sample is further provided with a known amount of one or more connected probes, prior to said amplification.
28. Method according to any of the preceding claims, further comprising quantification of the relative or n absolute abundance of target nucleic acid in said sample or sub-sample.
29. Method according to any of the preceding claims for detecting a nucleotide polymorphism, preferably a single nucleotide polymorphism.
30. Method according to any of the preceding claims, for the detection of multiple single stranded target nucleic acids.
31. Method according to claim 30, wherein said multiple single stranded target nucleic acids are detected through the detection of multiple amplicons.
32. Method according to claim 31, wherein at least two of said multiple amplicons can be discriminated on the basis of a difference in size of said at least two amplicons.
33. Method according to any of the preceding claims, for determining the absolute or relative abundance of multiple single stranded target nucleic acids in the sample.
34. Method according to any of the preceding claims for the detection of a breakpoint region in rearranged nucleic acid.
35. Method for detecting in a sample, comprising a plurality of sample nucleic acids of different sequence, the presence of at least one specific single stranded target nucleic acid sequence comprising a first and a second segment, and optionally a third segment being located between the first and second segments, the segments located essentially adjacent to one another, comprising, in the same reaction vessel, the steps of:
- contacting the sample nucleic acids with a plurality of different probe sets, each probe set comprising - a first nucleic acid probe having - a first target specific region complementary to the first segment of said target nucleic acid sequence and - a first non-complementary region, 3'from the first region, being essentially non-complementary to said target nucleic acid sequence, comprising a first tag sequence, - a second nucleic acid probe having - a second target specific region complementary to the second segment of said target nucleic acid sequence and - a second non-complementary region, 5'from the second region, being essentially non-complementary to said target nucleic acid sequence, comprising a second tag sequence, and, optionally, - a third nucleic acid probe having a third target specific region, complementary to the third segment, - incubating the plurality of sample nucleic acids with the probes allowing hybridisation of complementary nucleic acids, - connecting to one another the first, second and optionally the third probes, hybridised to the first, second and, if present, third segment of the same target nucleic acid sequence, respectively, the hybridised probes being located essentially adjacent to one another, forming a connected probe assembly, - amplifying the connected probe assemblies, wherein amplification is initiated by binding of a first nucleic acid primer specific for the first tag sequence followed by elongation thereof, detecting an amplicon, wherein at least one nucleic acid probe comprises enzymatic template directed polymerised nucleic acid prior to the hybridisation step.
- contacting the sample nucleic acids with a plurality of different probe sets, each probe set comprising - a first nucleic acid probe having - a first target specific region complementary to the first segment of said target nucleic acid sequence and - a first non-complementary region, 3'from the first region, being essentially non-complementary to said target nucleic acid sequence, comprising a first tag sequence, - a second nucleic acid probe having - a second target specific region complementary to the second segment of said target nucleic acid sequence and - a second non-complementary region, 5'from the second region, being essentially non-complementary to said target nucleic acid sequence, comprising a second tag sequence, and, optionally, - a third nucleic acid probe having a third target specific region, complementary to the third segment, - incubating the plurality of sample nucleic acids with the probes allowing hybridisation of complementary nucleic acids, - connecting to one another the first, second and optionally the third probes, hybridised to the first, second and, if present, third segment of the same target nucleic acid sequence, respectively, the hybridised probes being located essentially adjacent to one another, forming a connected probe assembly, - amplifying the connected probe assemblies, wherein amplification is initiated by binding of a first nucleic acid primer specific for the first tag sequence followed by elongation thereof, detecting an amplicon, wherein at least one nucleic acid probe comprises enzymatic template directed polymerised nucleic acid prior to the hybridisation step.
36. Nucleic acid probe set for use in the method according to any of the preceding claims, wherein the probes are capable of hybridising to adjacent sites on a DNA sequence which is complementary to a naturally occurring mRNA but having essentially separated target sequence on chromosomal DNA.
37. Nucleic acid probe for use in a method according to claim 18 or 35.
38. Mixture of nucleic acids comprising two or more probes according to claim 37.
39. Kit for performing the method according to any of the claims 1-35, comprising a nucleic acid probe according to claim 37 or a mixture of probes according to claim 36 or 38.
40. Method for ligating at least two nucleic acid to each other comprising incubating a sample comprising said nucleic acids with a thermostable nucleic acid ligation enzyme under suitable conditions, wherein said ligation enzyme is capable of being essentially inactivated by incubating said sample for 10 minutes at a temperature of approximately 95 °C.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00200506A EP1130113A1 (en) | 2000-02-15 | 2000-02-15 | Multiplex ligation dependent amplification assay |
| EP00200506.4 | 2000-02-15 | ||
| PCT/EP2001/001739 WO2001061033A2 (en) | 2000-02-15 | 2001-02-15 | Multiplex ligatable probe amplification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2400240A1 true CA2400240A1 (en) | 2001-08-23 |
| CA2400240C CA2400240C (en) | 2012-12-18 |
Family
ID=8171015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2400240A Expired - Lifetime CA2400240C (en) | 2000-02-15 | 2001-02-15 | Multiplex ligatable probe amplification |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6955901B2 (en) |
| EP (2) | EP1130113A1 (en) |
| AU (1) | AU2001246439A1 (en) |
| CA (1) | CA2400240C (en) |
| WO (1) | WO2001061033A2 (en) |
Families Citing this family (139)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2255599C (en) | 1996-04-25 | 2006-09-05 | Bioarray Solutions, Llc | Light-controlled electrokinetic assembly of particles near surfaces |
| CA2410950A1 (en) * | 2000-05-30 | 2001-12-06 | Hans-Michael Wenz | Methods for detecting target nucleic acids using coupled ligation and amplification |
| US7087414B2 (en) | 2000-06-06 | 2006-08-08 | Applera Corporation | Methods and devices for multiplexing amplification reactions |
| US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
| DE60117556T2 (en) | 2000-06-21 | 2006-11-02 | Bioarray Solutions Ltd. | MULTI-ANALYTIC MOLECULAR ANALYSIS THROUGH THE USE OF APPLICATION SPECIFIC RAPID PARTICLE ARRAYS |
| US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
| NZ532947A (en) | 2001-10-15 | 2006-01-27 | Bioarray Solutions Ltd | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| EP1319718A1 (en) * | 2001-12-14 | 2003-06-18 | Keygene N.V. | High throughput analysis and detection of multiple target sequences |
| US20060088826A1 (en) * | 2001-12-28 | 2006-04-27 | Van Eijk Michael Josephus Ther | Discrimination and detection of target nucleotide sequences using mass spectrometry |
| AU2003220254B2 (en) | 2002-03-13 | 2008-09-18 | Syngenta Participations, Ag. | Nucleic acid detection method |
| CA2499077A1 (en) * | 2002-09-19 | 2004-04-01 | Applera Corporation | Methods and composition for detecting targets |
| CA2499360A1 (en) * | 2002-09-19 | 2004-04-01 | Applera Corporation | Methods and compositions for detecting targets |
| EP1558756A4 (en) * | 2002-10-23 | 2006-09-27 | Applera Corp | Methods and composition for detecting targets |
| AU2003298655A1 (en) | 2002-11-15 | 2004-06-15 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
| US7597936B2 (en) * | 2002-11-26 | 2009-10-06 | University Of Utah Research Foundation | Method of producing a pigmented composite microporous material |
| US8323897B2 (en) | 2002-12-04 | 2012-12-04 | Applied Biosystems, Llc | Multiplex amplification of polynucleotides |
| US7255994B2 (en) | 2003-06-10 | 2007-08-14 | Applera Corporation | Ligation assay |
| EP1641936B1 (en) | 2003-06-17 | 2010-08-04 | Human Genetic Signatures PTY Ltd. | Methods for genome amplification |
| EP1633888B1 (en) * | 2003-06-17 | 2009-03-25 | Keygene N.V. | Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs |
| EP1500709A1 (en) * | 2003-07-21 | 2005-01-26 | Academisch Ziekenhuis bij de Universiteit van Amsterdam | Means and methods for detecting a risk of infarction related to atherosclerosis |
| WO2005026389A2 (en) * | 2003-08-29 | 2005-03-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Ligation-based method of analysis of single nucleotide polymorphisms on genomic dna |
| US8808991B2 (en) | 2003-09-02 | 2014-08-19 | Keygene N.V. | Ola-based methods for the detection of target nucleic avid sequences |
| EP1602733A1 (en) * | 2004-06-02 | 2005-12-07 | Keygene N.V. | Detection of target nucleotide sequences using an asymmetric oligonucleotide ligation assay |
| JP4714148B2 (en) * | 2003-09-04 | 2011-06-29 | ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド | Nucleic acid detection assay |
| US7927796B2 (en) | 2003-09-18 | 2011-04-19 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
| CN1882699A (en) | 2003-09-22 | 2006-12-20 | 佰尔瑞溶液有限公司 | Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules |
| US7862849B2 (en) * | 2003-10-17 | 2011-01-04 | Massachusetts Institute Of Technology | Nanocontact printing |
| US7563569B2 (en) | 2003-10-28 | 2009-07-21 | Michael Seul | Optimization of gene expression analysis using immobilized capture probes |
| ES2533876T3 (en) | 2003-10-29 | 2015-04-15 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by double stranded DNA fragmentation |
| US8168777B2 (en) | 2004-04-29 | 2012-05-01 | Human Genetic Signatures Pty. Ltd. | Bisulphite reagent treatment of nucleic acid |
| US7785843B2 (en) * | 2004-06-23 | 2010-08-31 | Sequenom, Inc. | Target-specific compomers and methods of use |
| WO2006005080A2 (en) * | 2004-06-30 | 2006-01-12 | Applera Corporation | Method for detection of a nucleic acid sequence |
| EP1776474A2 (en) | 2004-07-23 | 2007-04-25 | (Osi) Eyetech, Inc. | Detection of oligonuleotides by dual hybridization |
| US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
| ATE476439T1 (en) | 2004-09-10 | 2010-08-15 | Human Genetic Signatures Pty | AMPLIFICATION BLOCKERS COMPRISING INTERCALATING NUCLEIC ACIDS (INA) CONTAINING INTERCALATING PSEUDONUCLEOTIDES (IPN) |
| EP1828411B1 (en) | 2004-12-03 | 2012-11-07 | Human Genetic Signatures PTY Ltd | Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
| US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
| EP1856293A2 (en) * | 2005-03-16 | 2007-11-21 | Compass Genetics, Llc | Methods and compositions for assay readouts on multiple analytical platforms |
| EP1874957A1 (en) * | 2005-04-20 | 2008-01-09 | Sedna Biotechnologies AB | Method for amplification |
| AU2006251866B2 (en) | 2005-05-26 | 2007-11-29 | Human Genetic Signatures Pty Ltd | Isothermal strand displacement amplification using primers containing a non-regular base |
| US8486629B2 (en) * | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
| US8343738B2 (en) | 2005-09-14 | 2013-01-01 | Human Genetic Signatures Pty. Ltd. | Assay for screening for potential cervical cancer |
| US20070092883A1 (en) * | 2005-10-26 | 2007-04-26 | De Luwe Hoek Octrooien B.V. | Methylation specific multiplex ligation-dependent probe amplification (MS-MLPA) |
| US8137936B2 (en) * | 2005-11-29 | 2012-03-20 | Macevicz Stephen C | Selected amplification of polynucleotides |
| US20070196849A1 (en) * | 2006-02-22 | 2007-08-23 | Applera Corporation | Double-ligation Method for Haplotype and Large-scale Polymorphism Detection |
| WO2007100243A1 (en) * | 2006-03-01 | 2007-09-07 | Keygene N.V. | High throughput sequence-based detection of snps using ligation assays |
| JP2009536525A (en) | 2006-05-10 | 2009-10-15 | ディクステリティー ダイアグノーティクス | Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
| US7897747B2 (en) * | 2006-05-25 | 2011-03-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby |
| US7833716B2 (en) | 2006-06-06 | 2010-11-16 | Gen-Probe Incorporated | Tagged oligonucleotides and their use in nucleic acid amplification methods |
| AU2007293187A1 (en) * | 2006-06-30 | 2008-03-13 | Rosetta Genomics Ltd | A method for detecting nucleic acids |
| US8383339B2 (en) * | 2006-08-28 | 2013-02-26 | Massachusetts Institute Of Technology | Liquid supramolecular nanostamping (LiSuNS) |
| US8053191B2 (en) | 2006-08-31 | 2011-11-08 | Westend Asset Clearinghouse Company, Llc | Iterative nucleic acid assembly using activation of vector-encoded traits |
| US20080090238A1 (en) * | 2006-10-12 | 2008-04-17 | Dan-Hui Dorothy Yang | Increased sensitivity of proximity ligation assays |
| US8778846B2 (en) * | 2006-12-04 | 2014-07-15 | General Electric Company | Composition, device and associated method |
| WO2008118998A2 (en) * | 2007-03-27 | 2008-10-02 | Primera Biosystems Inc. | Method for multiplex detection and quantitation of nucleic acids |
| US9512470B2 (en) | 2007-07-11 | 2016-12-06 | Pathofinder Holding B.V. | Method for the simultaneous detection of multiple nucleic acid sequences in a sample |
| EP2014774A1 (en) * | 2007-07-11 | 2009-01-14 | Pathofinder B.V. | Assay for the simulataneous detection of multiple nucleic acid sequences in a sample |
| WO2009067743A1 (en) | 2007-11-27 | 2009-06-04 | Human Genetic Signatures Pty Ltd | Enzymes for amplification and copying bisulphite modified nucleic acids |
| US8003326B2 (en) * | 2008-01-02 | 2011-08-23 | Children's Medical Center Corporation | Method for diagnosing autism spectrum disorder |
| US20090176226A1 (en) * | 2008-01-02 | 2009-07-09 | Children's Medical Center Corporation | Method for diagnosing autism spectrum disorder |
| US8852864B2 (en) | 2008-01-17 | 2014-10-07 | Sequenom Inc. | Methods and compositions for the analysis of nucleic acids |
| EP2356253A1 (en) * | 2008-11-05 | 2011-08-17 | Stichting Sanquin Bloedvoorziening | Means and methods for investigating nucleic acid sequences |
| JP5854838B2 (en) | 2008-11-07 | 2016-02-09 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | Allele amplification bias |
| US20120021949A1 (en) * | 2009-03-31 | 2012-01-26 | Centre Hospitalier Universitaire Vaudois | Methylation Ligation-Dependent Macroarray (MLM) |
| US9976177B2 (en) * | 2009-04-01 | 2018-05-22 | Dxterity Diagnostics Incorporated | Chemical ligation dependent probe amplification (CLPA) |
| WO2010129937A2 (en) * | 2009-05-08 | 2010-11-11 | Life Technologies Corporation | Methods for detecting genetic variations in dna samples |
| WO2011011426A2 (en) | 2009-07-20 | 2011-01-27 | Bar Harbor Biotechnology, Inc. | Methods for assessing disease risk |
| WO2011066330A2 (en) * | 2009-11-24 | 2011-06-03 | Life Technologies Corporation | Selective amplification of polynucleotide sequences |
| EP2519647A1 (en) * | 2009-12-31 | 2012-11-07 | Ventana Medical Systems, Inc. | Methods for producing uniquely specific nucleic acid probes |
| GB201001088D0 (en) | 2010-01-23 | 2010-03-10 | Trillion Genomics Ltd | Detection |
| CN101864482A (en) * | 2010-02-10 | 2010-10-20 | 深圳出入境检验检疫局动植物检验检疫技术中心 | MLCR probe, two-step reaction mode and suspension chip detection capture probe |
| US20120034603A1 (en) * | 2010-08-06 | 2012-02-09 | Tandem Diagnostics, Inc. | Ligation-based detection of genetic variants |
| US10167508B2 (en) | 2010-08-06 | 2019-01-01 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities |
| US11031095B2 (en) | 2010-08-06 | 2021-06-08 | Ariosa Diagnostics, Inc. | Assay systems for determination of fetal copy number variation |
| AU2015202048B2 (en) * | 2010-08-06 | 2017-09-07 | F. Hoffmann-La Roche Ag | Ligation-based detection of genetic variants |
| US10533223B2 (en) | 2010-08-06 | 2020-01-14 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| US8700338B2 (en) | 2011-01-25 | 2014-04-15 | Ariosa Diagnosis, Inc. | Risk calculation for evaluation of fetal aneuploidy |
| AU2015201176B2 (en) * | 2010-08-06 | 2017-09-07 | F. Hoffmann-La Roche Ag | Assay systems for determination of source contribution in a sample |
| US11203786B2 (en) | 2010-08-06 | 2021-12-21 | Ariosa Diagnostics, Inc. | Detection of target nucleic acids using hybridization |
| US20130040375A1 (en) | 2011-08-08 | 2013-02-14 | Tandem Diagnotics, Inc. | Assay systems for genetic analysis |
| US20140342940A1 (en) | 2011-01-25 | 2014-11-20 | Ariosa Diagnostics, Inc. | Detection of Target Nucleic Acids using Hybridization |
| US20130261003A1 (en) | 2010-08-06 | 2013-10-03 | Ariosa Diagnostics, In. | Ligation-based detection of genetic variants |
| JP6118725B2 (en) | 2010-11-12 | 2017-04-19 | ジェン９・インコーポレイテッドＧｅｎ９，ＩＮＣ． | Methods and devices for nucleic acid synthesis |
| US10457935B2 (en) | 2010-11-12 | 2019-10-29 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| EP3348640B1 (en) | 2010-11-24 | 2019-09-11 | Kaneka Corporation | Amplified nucleic acid detection method and detection device |
| WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
| US9994897B2 (en) | 2013-03-08 | 2018-06-12 | Ariosa Diagnostics, Inc. | Non-invasive fetal sex determination |
| US8756020B2 (en) | 2011-01-25 | 2014-06-17 | Ariosa Diagnostics, Inc. | Enhanced risk probabilities using biomolecule estimations |
| US11270781B2 (en) | 2011-01-25 | 2022-03-08 | Ariosa Diagnostics, Inc. | Statistical analysis for non-invasive sex chromosome aneuploidy determination |
| US10131947B2 (en) | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
| KR101322880B1 (en) * | 2011-03-04 | 2013-10-29 | 한국과학기술원 | Method for Analyzing gene Using SDL-PCR |
| WO2012138789A2 (en) | 2011-04-04 | 2012-10-11 | Netherlands Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment |
| EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
| CN103827317B (en) | 2011-05-17 | 2016-09-07 | 德克斯特里蒂诊断公司 | For detecting method and the composition of target nucleic acid |
| AU2012281242B2 (en) | 2011-07-08 | 2016-12-22 | Keygene N.V. | Sequence based genotyping based on oligonucleotide ligation assays |
| JP2014526899A (en) | 2011-08-26 | 2014-10-09 | ジェン９・インコーポレイテッド | Compositions and methods for high fidelity assembly of nucleic acids |
| US8712697B2 (en) | 2011-09-07 | 2014-04-29 | Ariosa Diagnostics, Inc. | Determination of copy number variations using binomial probability calculations |
| MX350658B (en) | 2011-09-07 | 2017-09-13 | Human Genetic Signatures Pty Ltd | Molecular detection assay. |
| WO2013038010A2 (en) * | 2011-09-16 | 2013-03-21 | Lexogen Gmbh | Nucleic acid transcription method |
| IN2014CN04405A (en) | 2011-12-14 | 2015-09-04 | Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Sport | |
| WO2013102150A1 (en) * | 2011-12-28 | 2013-07-04 | Ricardo Mancebo | Reagents and methods for autoligation chain reaction |
| US10648030B2 (en) | 2012-01-13 | 2020-05-12 | Affymetrix, Inc. | Methods of determining the presence or absence of a plurality of target polynucleotides in a sample |
| WO2013133708A1 (en) | 2012-03-07 | 2013-09-12 | Stichting Vu-Vumc | Compositions and methods for diagnosing and treating intellectual disability syndrome, autism and autism related disorders |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| EP4001427A1 (en) | 2012-04-24 | 2022-05-25 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| CN104254620B (en) | 2012-04-27 | 2022-11-08 | 株式会社钟化 | Method for amplifying nucleic acid and method for detecting amplified nucleic acid |
| US10289800B2 (en) | 2012-05-21 | 2019-05-14 | Ariosa Diagnostics, Inc. | Processes for calculating phased fetal genomic sequences |
| AU2013280661A1 (en) | 2012-06-25 | 2015-01-22 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| EP2875156A4 (en) | 2012-07-19 | 2016-02-24 | Ariosa Diagnostics Inc | Multiplexed sequential ligation-based detection of genetic variants |
| JP6234463B2 (en) * | 2012-09-10 | 2017-11-22 | ジーンスカイ ダイアグノスティクス（スーツォウ） インコーポレーテッドＧｅｎｅｓｋｙ Ｄｉａｇｎｏｓｔｉｃｓ （Ｓｕｚｈｏｕ） Ｉｎｃ． | Nucleic acid multiplex analysis method |
| JPWO2014156513A1 (en) * | 2013-03-29 | 2017-02-16 | 日本碍子株式会社 | Mutation detection method |
| CN103266180A (en) * | 2013-06-07 | 2013-08-28 | 徐堤 | General multiplex ligation-dependent probe amplification kit |
| EP3024943A1 (en) * | 2013-07-23 | 2016-06-01 | Universitat Autònoma de Barcelona | Inverse multiplex ligation-dependent probe amplification (imlpa), an in vitro method of genotyping multiple inversions |
| FR3010530B1 (en) | 2013-09-11 | 2015-10-09 | Univ Rouen | METHOD OF DIAGNOSING MALIGNANT HEMOPATHIES AND KIT THEREFOR |
| JP6691380B2 (en) | 2013-11-22 | 2020-04-28 | 株式会社カネカ | Method for detecting short RNA |
| US20160340722A1 (en) * | 2014-01-22 | 2016-11-24 | Adam Platt | Methods And Systems For Detecting Genetic Mutations |
| EP3117009B1 (en) * | 2014-03-11 | 2020-04-08 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods and kits for classifying diffuse large b-cell lymphoma (dlbcl) into gcb-dlbcl or into abc-dlbcl |
| KR102538394B1 (en) | 2014-06-10 | 2023-06-01 | 디엑스테리티 다이아그노스틱스 인코포레이티드 | Devices and methods for collecting and stabilizing biological samples |
| US11091810B2 (en) * | 2015-01-27 | 2021-08-17 | BioSpyder Technologies, Inc. | Focal gene expression profiling of stained FFPE tissues with spatial correlation to morphology |
| CN107002140A (en) * | 2014-09-26 | 2017-08-01 | 双孔人公司 | The target sequence detected by the nanoaperture of synthesising probing needle is detected |
| EP3209777A4 (en) * | 2014-10-21 | 2018-07-04 | Gen9, Inc. | Methods for nucleic acid assembly |
| WO2016170121A1 (en) * | 2015-04-23 | 2016-10-27 | Pathofinder B.V. | Method for the simultaneous detection of multiple nucleic acid sequences in a sample |
| AU2016296594B2 (en) * | 2015-07-17 | 2020-07-09 | Luminex Corporation | Methods and compositions for catalytic assays |
| US11118216B2 (en) | 2015-09-08 | 2021-09-14 | Affymetrix, Inc. | Nucleic acid analysis by joining barcoded polynucleotide probes |
| WO2017046192A1 (en) * | 2015-09-18 | 2017-03-23 | Biotype Diagnostic Gmbh | Confirmation test for primary nucleic acid amplification products in a continuous reaction preparation and direct evaluation by means of electrophoretic methods |
| US11486873B2 (en) | 2016-03-31 | 2022-11-01 | Ontera Inc. | Multipore determination of fractional abundance of polynucleotide sequences in a sample |
| GB201612011D0 (en) * | 2016-07-11 | 2016-08-24 | Glaxosmithkline Ip Dev Ltd | Novel processes for the production of oligonucleotides |
| ES2848715T3 (en) | 2016-10-24 | 2021-08-11 | Ontera Inc | Fractional abundance of polynucleotide sequences in a sample |
| JP7358388B2 (en) * | 2018-05-03 | 2023-10-10 | ベクトン・ディキンソン・アンド・カンパニー | Molecular barcoding at opposite transcript ends |
| AU2019287163A1 (en) | 2018-06-12 | 2020-12-03 | Keygene N.V. | Nucleic acid amplification method |
| CA3117898A1 (en) | 2018-11-05 | 2020-05-14 | Centre Henri Becquerel | Method for diagnosing a cancer and associated kit |
| FR3088077B1 (en) | 2018-11-05 | 2023-04-21 | Centre Henri Becquerel | CANCER DIAGNOSTIC METHOD AND ASSOCIATED KIT |
| CN109355437A (en) * | 2018-12-11 | 2019-02-19 | 上海捷诺生物科技有限公司 | A kind of respiratory pathogen Multiple detection kit |
| WO2020169830A1 (en) | 2019-02-21 | 2020-08-27 | Keygene N.V. | Genotyping of polyploids |
| WO2020191376A1 (en) | 2019-03-21 | 2020-09-24 | Sherlock Biosciences | System |
| EP3947738A1 (en) | 2019-03-28 | 2022-02-09 | Institut National De La Sante Et De La Recherche Medicale - Inserm | Classification of b-cell non-hodgkin lymphomas |
| CN111621551B (en) * | 2019-07-31 | 2021-10-26 | 深圳闪量科技有限公司 | Multiplex ligation probe microarray detection |
| WO2024006552A1 (en) | 2022-07-01 | 2024-01-04 | Sherlock Biosciences, Inc. | Ambient temperature nucleic acid amplification and detection |
| WO2024062603A1 (en) * | 2022-09-22 | 2024-03-28 | 株式会社日立ハイテク | Point mutation rate detection method |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5942391A (en) * | 1994-06-22 | 1999-08-24 | Mount Sinai School Of Medicine | Nucleic acid amplification method: ramification-extension amplification method (RAM) |
| WO1996015271A1 (en) * | 1994-11-16 | 1996-05-23 | Abbott Laboratories | Multiplex ligations-dependent amplification |
| US5888731A (en) * | 1995-08-30 | 1999-03-30 | Visible Genetics Inc. | Method for identification of mutations using ligation of multiple oligonucleotide probes |
| AU714486B2 (en) * | 1995-11-21 | 2000-01-06 | Yale University | Unimolecular segment amplification and detection |
| US6852487B1 (en) * | 1996-02-09 | 2005-02-08 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| EP0912761A4 (en) * | 1996-05-29 | 2004-06-09 | Cornell Res Foundation Inc | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US6312892B1 (en) * | 1996-07-19 | 2001-11-06 | Cornell Research Foundation, Inc. | High fidelity detection of nucleic acid differences by ligase detection reaction |
| AUPO524897A0 (en) * | 1997-02-21 | 1997-03-20 | Johnson & Johnson Research Pty. Limited | Method of amplifying specific nucleic acid target sequences |
| AU780119B2 (en) * | 1999-01-06 | 2005-03-03 | Cornell Research Foundation Inc. | Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing |
| US6812005B2 (en) * | 2000-02-07 | 2004-11-02 | The Regents Of The University Of California | Nucleic acid detection methods using universal priming |
-
2000
- 2000-02-15 EP EP00200506A patent/EP1130113A1/en not_active Withdrawn
-
2001
- 2001-02-15 WO PCT/EP2001/001739 patent/WO2001061033A2/en active Search and Examination
- 2001-02-15 CA CA2400240A patent/CA2400240C/en not_active Expired - Lifetime
- 2001-02-15 AU AU2001246439A patent/AU2001246439A1/en not_active Abandoned
- 2001-02-15 EP EP01919289.7A patent/EP1255871B1/en not_active Expired - Lifetime
-
2002
- 2002-08-15 US US10/218,567 patent/US6955901B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2400240C (en) | 2012-12-18 |
| AU2001246439A1 (en) | 2001-08-27 |
| WO2001061033A2 (en) | 2001-08-23 |
| EP1255871A2 (en) | 2002-11-13 |
| WO2001061033A3 (en) | 2002-03-28 |
| US20030108913A1 (en) | 2003-06-12 |
| EP1130113A1 (en) | 2001-09-05 |
| US6955901B2 (en) | 2005-10-18 |
| EP1255871B1 (en) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2400240A1 (en) | Multiplex ligatable probe amplification | |
| AU2021200461B2 (en) | Nucleic acid probe and method of detecting genomic fragments | |
| USRE44265E1 (en) | Nucleic acid amplification method | |
| CA2135607C (en) | Chemical method for the analysis of dna sequences | |
| US7223536B2 (en) | Methods for detecting single nucleotide polymorphisms | |
| US20060088826A1 (en) | Discrimination and detection of target nucleotide sequences using mass spectrometry | |
| CN1981052A (en) | Detection of chromosomal disorders | |
| WO1999040226A3 (en) | Determination of a genotype of an amplification product at multiple allelic sites | |
| WO2001057256A3 (en) | Rolling circle amplification assay for nucleic acid analysis | |
| EP3080291B1 (en) | Nucleic acid detection and quantification | |
| US20030082572A1 (en) | Methods and compositions for nucleotide analysis | |
| CN110878356A (en) | Multiplex nucleic acid index amplification probe and tumor multi-target detection application thereof | |
| IL300973A (en) | Kits for detecting one or more target analytes in a sample and methods of making and using the same | |
| US6403340B1 (en) | Template chain reaction | |
| CA2472970A1 (en) | New detection format for hot start real time polymerase chain reaction | |
| CN108048533B (en) | Molecule detection method based on three-way connection-nucleic acid molecule line transducer | |
| US20180237853A1 (en) | Methods, Compositions and Kits for Detection of Mutant Variants of Target Genes | |
| CN102296116A (en) | Method for signal amplification and detection of target sequence of DNA | |
| CN102660640A (en) | Method for specific signal amplification and detection of DNA targeted sequence | |
| US20090305288A1 (en) | Methods for amplifying nucleic acids and for analyzing nucleic acids therewith | |
| EP4083229A1 (en) | Methods and compositions for nucleic acid detection | |
| CN113046421A (en) | Method for asymmetrically amplifying target nucleic acid | |
| CN103882128A (en) | Method for signal amplification and detection on target deoxyribonucleic acid (DNA) sequence at normal temperature | |
| US6200753B1 (en) | Detection of nucleic acid sequences | |
| CN110603328A (en) | Quantitative PCR amplification primer pair and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20210215 |